Robert Renninger

CIK: 0002037968

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (21.1%)

Position reduction

Option Exercises (M)4 (21.1%)

Derivative conversions

Awards (A)11 (57.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LONA

LeonaBio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

LONA
LeonaBio, Inc.
Apr 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
300K shares-
LONA
LeonaBio, Inc.
Mar 4, 2026
Sale(S)
Direct
906 shares at avg. $5.37$5K
LONA
LeonaBio, Inc.
Mar 3, 2026
Exercise(M)
Direct
3.9K shares-
ATHA
Athira Pharma, Inc.
Jan 2, 2026
Sale(S)
Direct
297 shares at avg. $6.88$2K
ATHA
Athira Pharma, Inc.
Dec 31, 2025
Exercise(M)
Direct
1.2K shares-
ATHA
Athira Pharma, Inc.
Dec 24, 2025
Award(A)
Stock Option (Right to Buy)
Direct
34.4K shares-
ATHA
Athira Pharma, Inc.
Nov 18, 2025
Award(A)
Direct
1K shares at avg. $2.31$2K
ATHA
Athira Pharma, Inc.
Jul 1, 2025
Sale(S)
Direct
2.9K shares at avg. $0.29$850.27
ATHA
Athira Pharma, Inc.
Jun 30, 2025
Exercise(M)
Direct
12.4K shares-
ATHA
Athira Pharma, Inc.
May 19, 2025
Award(A)
Direct
10K shares at avg. $0.23$2K
ATHA
Athira Pharma, Inc.
Mar 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
73.4K shares-
ATHA
Athira Pharma, Inc.
Mar 3, 2025
Award(A)
Restricted Stock Units
Direct
39K shares-
ATHA
Athira Pharma, Inc.
Mar 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
58.5K shares-
ATHA
Athira Pharma, Inc.
Mar 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
73.4K shares-
ATHA
Athira Pharma, Inc.
Jan 2, 2025
Sale(S)
Direct
2.9K shares at avg. $0.56$2K
ATHA
Athira Pharma, Inc.
Dec 31, 2024
Exercise(M)
Direct
12.4K shares-
ATHA
Athira Pharma, Inc.
Nov 18, 2024
Award(A)
Direct
3.7K shares at avg. $0.55$2K
ATHA
Athira Pharma, Inc.
Oct 1, 2024
Award(A)
Stock Option (Right to Buy)
Direct
37.1K shares-
ATHA
Athira Pharma, Inc.
Oct 1, 2024
Award(A)
Restricted Stock Units
Direct
37.1K shares-

		Type	Shares	Price		Ownership
Apr 9, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	300,000	-	-	Direct
Mar 4, 2026	LONA LeonaBio, Inc.	Sale(S)	906	$5.37	$4,865	Direct
Mar 3, 2026	LONA LeonaBio, Inc.	Exercise(M)	3,900	-	$0	Direct
Jan 2, 2026	ATHA Athira Pharma, Inc.	Sale(S)	297	$6.88	$2,043	Direct
Dec 31, 2025	ATHA Athira Pharma, Inc.	Exercise(M)	1,236	-	$0	Direct
Dec 24, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	34,358	-	-	Direct
Nov 18, 2025	ATHA Athira Pharma, Inc.	Award(A)	1,000	$2.31	$2,310	Direct
Jul 1, 2025	ATHA Athira Pharma, Inc.	Sale(S)	2,897	$0.29	$850	Direct
Jun 30, 2025	ATHA Athira Pharma, Inc.	Exercise(M)	12,359	-	-	Direct
May 19, 2025	ATHA Athira Pharma, Inc.	Award(A)	10,000	$0.23	$2,312	Direct
Mar 3, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	73,350	-	-	Direct
Mar 3, 2025	ATHA Athira Pharma, Inc.	Award(A) Restricted Stock Units	39,000	-	-	Direct
Mar 3, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	58,500	-	-	Direct
Mar 3, 2025	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	73,350	-	-	Direct
Jan 2, 2025	ATHA Athira Pharma, Inc.	Sale(S)	2,881	$0.56	$1,619	Direct
Dec 31, 2024	ATHA Athira Pharma, Inc.	Exercise(M)	12,359	-	$0	Direct
Nov 18, 2024	ATHA Athira Pharma, Inc.	Award(A)	3,651	$0.55	$2,008	Direct
Oct 1, 2024	ATHA Athira Pharma, Inc.	Award(A) Stock Option (Right to Buy)	37,077	-	-	Direct
Oct 1, 2024	ATHA Athira Pharma, Inc.	Award(A) Restricted Stock Units	37,077	-	-	Direct

1-19 of 19 transactions

About Renninger Robert

Renninger Robert (SEC CIK 0002037968) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of LeonaBio, Inc. (LONA).

Signal8 holds 10 ownership filings by Renninger Robert (1 Form 3, 9 Form 4), filed between Oct 3, 2024 and Apr 13, 2026. Those filings report 19 transactions, from Oct 1, 2024 to Apr 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Renninger Robert's filings is in BOTHELL, WA.

Recent filings by Renninger Robert

Apr 9, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Mar 4, 2026: Open-market sale of LONA shares (Form 4, code S).
Mar 3, 2026: Option exercise of LONA shares (Form 4, code M).
Jan 2, 2026: Open-market sale of ATHA shares (Form 4, code S).
Dec 31, 2025: Option exercise of ATHA shares (Form 4, code M).

Other insiders filing for LeonaBio, Inc. (LONA)

How to read Form 4 transaction codes